🇺🇸 FDA
Patent

US 10941200

TREM2 cleavage modulators and uses thereof

granted A61PA61P21/00A61P25/16

Quick answer

US patent 10941200 (TREM2 cleavage modulators and uses thereof) held by Ludwig-Maximilians-Universitat Munchen expires Mon Mar 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Ludwig-Maximilians-Universitat Munchen
Grant date
Tue Mar 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61P, A61P21/00, A61P25/16, A61P25/28